TY - JOUR
T1 - Advanced systems for glucocorticoids' dermal delivery
AU - Raposo, Sara Caliço
AU - Simões, Sandra Dias
AU - Almeida, António José
AU - Ribeiro, Helena Margarida
N1 - Funding Information:
Authors gratefully acknowledge the support from Fundac¸ão para a Ciência e Tecnologia (Portugal), FEDER (doctoral grant SFRH/BDE/33550/2009 and strategic project PEst-OE/SAU/UI4013/2011) and Laboratório Edol S.A.
PY - 2013/6
Y1 - 2013/6
N2 - Introduction: Although the skin provides a natural physical barrier against particle penetration, there are opportunities to deliver therapeutic agents through this barrier. With rapid developments in materials science, pharmaceutics, and biotechnology, new systems have emerged for topical glucocorticoids (TG) delivery. Despite being a mature class of drugs, TG are still the most frequently prescribed drugs by dermatologists, explaining the interest on this field. Areas covered: Over the years, research has focused on strategies to optimize the potency of steroids while minimizing adverse effects. Several attempts have been made to increase the safety of TG treatment, including new application schedules, special vehicles, and new synthesized agents. This paper gives an overview on the conventional and advanced vehicles used to deliver TG, including strategies to improve the delivery and accumulation of TG. The therapeutic advantages of TG delivery to the epidermis are discussed with a special focus on new drug-delivery systems for topical application. Expert opinion: New technologies have been developed for TG delivery, and studies are currently underway in order to obtain improved benefit/risk ratio. A rationale development approach that integrates simple formulations would help to develop vehicles with these features.
AB - Introduction: Although the skin provides a natural physical barrier against particle penetration, there are opportunities to deliver therapeutic agents through this barrier. With rapid developments in materials science, pharmaceutics, and biotechnology, new systems have emerged for topical glucocorticoids (TG) delivery. Despite being a mature class of drugs, TG are still the most frequently prescribed drugs by dermatologists, explaining the interest on this field. Areas covered: Over the years, research has focused on strategies to optimize the potency of steroids while minimizing adverse effects. Several attempts have been made to increase the safety of TG treatment, including new application schedules, special vehicles, and new synthesized agents. This paper gives an overview on the conventional and advanced vehicles used to deliver TG, including strategies to improve the delivery and accumulation of TG. The therapeutic advantages of TG delivery to the epidermis are discussed with a special focus on new drug-delivery systems for topical application. Expert opinion: New technologies have been developed for TG delivery, and studies are currently underway in order to obtain improved benefit/risk ratio. A rationale development approach that integrates simple formulations would help to develop vehicles with these features.
KW - Conventional systems
KW - Corticoids
KW - Dermal delivery
KW - Epidermal targeting
KW - Nanoparticulate systems
UR - http://www.scopus.com/inward/record.url?scp=84878054508&partnerID=8YFLogxK
U2 - 10.1517/17425247.2013.778824
DO - 10.1517/17425247.2013.778824
M3 - Review article
C2 - 23544712
AN - SCOPUS:84878054508
SN - 1742-5247
VL - 10
SP - 857
EP - 877
JO - Expert Opinion on Drug Delivery
JF - Expert Opinion on Drug Delivery
IS - 6
ER -